AN2 Therapeutics, Inc. (ANTX)
Market Closed
17 Jul, 20:00
NASDAQ (NGS) NASDAQ (NGS) Primary 
XHAM $
4. 68
+0.01
+0.2141%
$
130.43M Market Cap
- P/E Ratio
- Div Yield
66,100 Volume
- Eps
$ 4.67
Previous Close Want to track ANTX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
AN2 Therapeutics, Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| HFT Hui Fai Tam Caitong International Asset Management Co. Ltd. | 2,600 | $8,892 | $11,934 | $3,042 | 34.21% |
| PLC Peapod Lane Capital LLC Peapod Lane Capital LLC | 59,854 | $80,232.48 | $283,707.96 | $203,475.48 | 253.61% |
 Yuen Man Lee Persistent Asset Partners Ltd. | 38,155 | $130,490 | $178,374.62 | $47,884.62 | 36.7% |
